Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.
Previously, our laboratory showed that Holstein cattle experimentally infected with Neospora caninum develop parasite-specific CD4+ cytotoxic T lymphocytes (CTL) that lyse infected, autologous target cells through a perforin-granzyme pathway. To identify specific parasite antigens inducing bovine CTL and helper T-lymphocyte responses for vaccine development against bovine neosporosis, the tachyzoite major surface proteins NcSAG1 and NcSRS2 were targeted. In whole tachyzoite antigen-expanded bovine T-lymphocyte lines, recombinant NcSRS2 induced potent memory CD4+- and CD8+-T-lymphocyte activation, as indicated by proliferation and gamma interferon (IFN-gamma) secretion, while recombinant NcSAG1 induced a minimal memory response. Subsequently, T-lymphocyte epitope-bearing peptides of NcSRS2 were mapped by using overlapping peptides covering the entire NcSRS2 sequence. Four experimentally infected cattle with six different major histocompatibility complex (MHC) class II haplotypes were the source of immune cells used to identify NcSRS2 peptides presented by Holstein MHC haplotypes. NcSRS2 peptides were mapped by using IFN-gamma secretion by rNcSRS2-stimulated, short-term T-lymphocyte cell lines, IFN-gamma enzyme-linked immunospot (ELISPOT) assay with peripheral blood mononuclear cells, and 51Cr release cytotoxicity assay of rNcSRS2-stimulated effector cells. Four N. caninum-infected Holstein cattle developed NcSRS2 peptide-specific T lymphocytes detected ex vivo in peripheral blood by IFN-gamma ELISPOT and in vitro by measuring T-lymphocyte IFN-gamma production and cytotoxicity. An immunodominant region of NcSRS2 spanning amino acids 133 to 155 was recognized by CD4+ T lymphocytes from the four cattle. These findings support investigation of subunit N. caninum vaccines incorporating NcSRS2 gene sequences or peptides for induction of NcSRS2 peptide-specific CTL and IFN-gamma-secreting T lymphocytes in cattle with varied MHC genotypes.
Staska
Lauren M
LM
Department of Veterinary Microbiology and Pathology, Bustad Hall, Washington State University, Pullman, WA 99164-7040, USA.
Davies
Christopher J
CJ
Brown
Wendy C
WC
McGuire
Travis C
TC
Suarez
Carlos E
CE
Park
Joo Youn
JY
Mathison
Bruce A
BA
Abbott
Jeffrey R
JR
Baszler
Timothy V
TV
D000595:Amino Acid Sequence; D000818:Animals; D000953:Antigens, Protozoan / Q000737:chemistry* / Q000276:immunology; D000954:Antigens, Surface / Q000737:chemistry* / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000469:parasitology; D002460:Cell Line; D003048:Coccidiosis / Q000276:immunology / Q000469:parasitology / Q000662:veterinary; D018604:Epitope Mapping; D018984:Epitopes, T-Lymphocyte; D005260:Female; D007371:Interferon-gamma / Q000378:metabolism*; D008969:Molecular Sequence Data; D018688:Neospora / Q000276:immunology*; D010455:Peptides / Q000737:chemistry / Q000276:immunology*; D015800:Protozoan Proteins / Q000737:chemistry* / Q000276:immunology; D016052:Protozoan Vaccines / Q000737:chemistry / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*
D000953:Antigens, Protozoan; D000954:Antigens, Surface; D018984:Epitopes, T-Lymphocyte; D010455:Peptides; D015800:Protozoan Proteins; D016052:Protozoan Vaccines; C115389:SRS2 protein, Neospora caninum; D007371:Interferon-gamma
J Vet Sci. 2004 Mar;5(1):29-39
15028883
Int J Parasitol. 2004 Mar 9;34(3):285-96
15003490
J Immunol. 1985 Aug;135(2):906-14
2409158
J Immunol. 1991 Nov 15;147(10):3501-6
1940350
J Immunol Methods. 1992 Feb 5;146(2):229-39
1538144
Infect Immun. 1992 Oct;60(10):4364-72
1383149
J Immunol. 1993 Aug 15;151(4):2024-31
8102155
Cell Immunol. 1996 May 1;169(2):218-25
8620549
J Clin Microbiol. 1996 Jun;34(6):1423-8
8735092
J Immunol. 1996 Oct 15;157(8):3480-90
8871647
Hum Immunol. 1996 Feb;45(2):79-93
8882405
Infect Immun. 1996 Oct;64(10):4330-8
8926107
Am J Vet Res. 1996 Nov;57(11):1559-62
8915429
Exp Parasitol. 1997 Jan;85(1):24-34
9024199
J Am Vet Med Assoc. 1997 Mar 1;210(5):672-4
9054999
Eur J Immunogenet. 1994 Aug;21(4):239-58
9098437
Eur J Immunogenet. 1994 Aug;21(4):259-89
9098438
Gene. 1998 Mar 27;210(1):103-8
9524237
J Parasitol. 1998 Apr;84(2):316-20
9576505
Immunogenetics. 1999 Nov;50(3-4):201-12
10602880
Int J Parasitol. 1999 Oct;29(10):1575-82
10608444
Int J Parasitol. 1999 Oct;29(10):1635-46
10608450
Int J Parasitol. 1999 Oct;29(10):1683-9
10608455
J Infect Dis. 2000 Jan;181(1):317-24
10608781
Infect Immun. 2000 Feb;68(2):969-72
10639474
J Vet Med Sci. 2000 Mar;62(3):347-51
10770613
Int J Parasitol. 2000 Aug;30(9):985-90
10980287
Parasitol Res. 2000 Sep;86(9):768-71
11002987
Clin Diagn Lab Immunol. 2000 Nov;7(6):893-8
11063494
Clin Microbiol Rev. 1998 Oct;11(4):569-88
9767056
Infect Immun. 1998 Nov;66(11):5322-8
9784539
Vet Parasitol. 1998 Dec 31;80(2):87-98
9870361
Immunol Rev. 1999 Feb;167:145-58
10319257
Vet Parasitol. 1999 Aug 1;84(3-4):349-67
10456423
Immunogenetics. 2000 Nov;52(1-2):101-6
11132144
Vaccine. 2001 Feb 8;19(13-14):1710-6
11166895
Vaccine. 2001 Jan 8;19(11-12):1381-90
11163660
J Vet Med Sci. 2001 Apr;63(4):445-8
11346181
Int J Parasitol. 2001 Nov;31(13):1523-34
11595240
J Clin Microbiol. 2001 Nov;39(11):3851-7
11682497
J Comp Pathol. 2002 Feb-Apr;126(2-3):79-94
11944996
Trends Parasitol. 2002 Sep;18(9):391-4
12377255
J Am Vet Med Assoc. 2002 Oct 15;221(8):1160-4
12387387
J Am Vet Med Assoc. 2002 Oct 15;221(8):1165-8
12387388
Trends Parasitol. 2002 Dec;18(12):546-52
12482540
Chin Med J (Engl). 2002 Oct;115(10):1448-52
12490084
J Parasitol. 2003 Feb;89(1):44-50
12659301
Korean J Parasitol. 2003 Mar;41(1):1-16
12666725
Infect Immun. 2003 Jun;71(6):3272-9
12761108
Vaccine. 2003 Jul 4;21(23):3307-18
12804862
J Comp Pathol. 2003 Aug-Oct;129(2-3):186-95
12921725
Parasite Immunol. 2003 Apr;25(4):185-8
12940961
Infect Immun. 2003 Nov;71(11):6615-9
14573684
Immunogenetics. 2004 Mar;55(12):797-810
14963618